A novel take on idiopathic pulmonary fibrosis disease progression: localised autoimmunity

Eur Respir J. 2023 May 18;61(5):2300653. doi: 10.1183/13993003.00653-2023. Print 2023 May.

Authors

Manali Mukherjee¹, Martin Kolb²

Affiliations

¹ Department of Medicine, McMaster University and Firestone Institute for Respiratory Health, St. Joseph's Healthcare, Hamilton, ON, Canada.
² Department of Medicine, McMaster University and Firestone Institute for Respiratory Health, St. Joseph's Healthcare, Hamilton, ON, Canada kolbm@mcmaster.ca.

PMID: 37208038
DOI: 10.1183/13993003.00653-2023

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Autoantibodies*
Autoimmunity
Disease Progression
Humans
Idiopathic Pulmonary Fibrosis* / immunology

Substances

Autoantibodies